Yazen Health secures €50 million to expand digital obesity care in Europe
Sweden’s Yazen Health has raised €50 million to scale its digital obesity care services across Europe, reflecting rising investment in tech-driven EU healthcare solutions.
Yazen Health, a Swedish digital healthcare provider based in Lund, has raised €50 million to expand its digital obesity care services across Europe, the company announced. The funding round was led by Verdane with participation from Evli Growth Partners.
The investment signals a growing recognition among European investors of obesity as a chronic disease requiring integrated care solutions. Yazen Health specializes in digital treatment models that address obesity’s long-term health impacts, reflecting a shift away from episodic interventions toward continuous, technology-enabled management.
The influx of capital is expected to enhance Yazen Health’s market position in the increasingly competitive digital health sector, particularly in obesity management. According to the company, the funding will support the deployment of its digital platform to new European markets, potentially increasing access to coordinated obesity care and introducing new treatment approaches.
For the European Union, the investment underlines a broader trend toward tech-driven healthcare innovation. Digital health platforms such as Yazen’s have the potential to influence EU healthcare policies by promoting integrated care pathways and expanding remote patient management, particularly for chronic conditions like obesity.
The expansion also raises questions about regulatory alignment across different EU member states. Digital health companies face varying national regulations, creating both opportunities for rapid market entry and challenges related to compliance and reimbursement.
For healthcare providers and insurers, the growth of digital obesity care could foster new partnerships and reshape reimbursement models. Investors are closely watching how digital health innovators like Yazen Health navigate the complex regulatory landscape and measure outcomes as part of wider healthcare transformation efforts.
The funding move by Verdane and Evli Growth Partners points to increasing investor confidence in digital health as a driver of healthcare efficiency and patient engagement across Europe.
